In this video, hosted by Drug Discovery World (DDW) and sponsored by Olink, we highlight how protein biomarker insights are helping researchers improve target selection and make more informed decisions across the R&D pipeline. Read More
Tech transfer is all about transferring technology, knowledge, and expertise from one phase of development to another, or from one facility to another, to ensure the successful replication and scaling up of biotherapeutic products. This involves several key activities such as knowledge and process transfer, process standardisation, quality and compliance,… Read More
In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform. How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More
In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More
Challenges in outsourcing drug discovery In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many… Read More
Mirus Bio outlines when to use transfection reagents, viral transduction or electroporation No single delivery method is ideal for all situations, but researchers may routinely employ a suboptimal approach for the sake of familiarity or to… Read More
Drug development technology has evolved rapidly in recent years, and with the industry advancement comes an increased capability of producing high-quality targeted large molecule drugs such as biologics and biosimilars. The significance of biologics is far-reaching, including treatment of rheumatologic diseases, cancer, diabetes and anaemia. The range of… Read More
Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as… Read More
Biotechs involved in drug discovery have to navigate increasingly complex regulatory environments across borders. Experienced experts and non-executive advisors to Arriello, Eric Caugant, Principal Consultant at Pharmacovigilance Systems Consulting & Board advisor to Arriello, and Judi Sills, JM Sills Consulting & Board advisor to Arriello, highlight the main differences between US… Read More
